Shade Matching of Universal Versus Conventional Nanohybrid Resin Composites in Class IV Restorations After Bleaching

August 4, 2024 updated by: Nayra Mohamed Mohab El Din Hussein Mohamed, Cairo University

Clinical Evaluation of Shade Matching and Marginal Discoloration of One Shade Universal Resin Composite Versus Conventional Nanohybrid Resin Composite in Class IV Restorations Before and After Tooth Bleaching .

The aim of the current study is to assess the shade matching potential of single shade universal resin composite versus conventional nanohybrid resin composite in class IV restorations after bleaching

Study Overview

Detailed Description

The use of a dental material that can blend into the surrounding tooth structure is increasing in popularity . A new technology , smart chromatic technology , has been introduced as the shade matching composite called omnichroma . Omnichroma has the ability to match the new lighter shade of the bleached teeth unlike the conventional composite . In this study , an investigation will be done to evaluate if this new technology will help to preserve the tooth structure and be more conservative , by avoiding the removal of the old anterior restorations after bleaching

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Cairo, Egypt, 12613
        • Recruiting
        • Faculty of Dentistry, Cairo University
        • Contact:
          • Faculty of dentistry cairo university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Candidates must have one or more existing class IV restoration.
  • Cases indicated for bleaching.
  • Cooperative patient approving to participate in the trial.

Exclusion Criteria:

  • Patients with severe medical conditions that might interfere with the study.
  • Patients with rampant caries or xerostomia.
  • Smoking.
  • Patients with history of hydrogen peroxide sensitivity , periodontal inflammation.
  • Lack of compliance.
  • Tempromandibular joint disorders.
  • Disabilities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: One shade universal composite
shade matching composite
A resin composite with new smart chromatic technology and chameleon effect. It has the ability to match the new lighter shade of the bleached teeth unlike the conventional composite
Active Comparator: Nanohybrid resin composite
Conventional Nanohybrid resin composite
A conventional resin composite with multiple shades

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in shade matching
Time Frame: Baseline, 2 days, 3, 6 and 12 months
Modified USPHS criteria with Alpha, Bravo ,Charlie and Delta scores (Categorical)
Baseline, 2 days, 3, 6 and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Marginal discoloration
Time Frame: Baseline, 2 days, 3, 6 and 12 months
Modified USPHS criteria with Alpha, Bravo, Charlie and Delta scores (Categorical)
Baseline, 2 days, 3, 6 and 12 months
Change in surface texture
Time Frame: Baseline, 2 days, 3, 6 and 12 months
Modified USPHS criteria with Alpha, Bravo, Charlie and Delta scores (Categorical)
Baseline, 2 days, 3, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: ahmed El Zoheiry, prof, Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2023

Primary Completion (Estimated)

February 1, 2025

Study Completion (Estimated)

October 1, 2025

Study Registration Dates

First Submitted

November 27, 2022

First Submitted That Met QC Criteria

November 27, 2022

First Posted (Actual)

December 6, 2022

Study Record Updates

Last Update Posted (Actual)

August 6, 2024

Last Update Submitted That Met QC Criteria

August 4, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Universal composite

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe